- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in gland pharma
Gland Pharma Shares Rally Nearly 8%; At 52-Week High After Q1 Earnings
Drug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter ended June 30, 2021, on account of robust sales in all markets.
Read More
Gland Pharma Q1 Net Profit Up 12 % To Rs 350.7 Cr
Consolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore for the same period a year ago
Read More
India's Gland Pharma jumps 20% in market debut
The stock opened at 1,710 rupees per share, higher than the IPO price of 1,500 rupees per share, giving the company a market value of 279.21 billion rupees, based on 163.3 million shares outstanding.
Read More
Gland Pharma Gets Sebi's Go-ahead To Float IPO
Apart from the fresh issue, there is an offer for sale (OFS) of a little over 3.4 crore shares as part of the initial public offering.
Read MoreHyderabad: Gland Pharma adopts 27 animals at Nehru Zoological Park
Hyderabad: Gland Pharma adopts 27 animals at Nehru Zoological Park
Read More
Gland Pharma Files DRHP With SEBI
Gland Pharma sells their products primarily under a business to business (“B2B”) model in over 60 countries as of March 31, 2020
Read More
India Raises Concerns Around Chinese Firm Fosun's Takeover Of Gland
The deal has won the approval of the Competition Commission of India (CCI) and India's Foreign Investment Promotion Board (FIPB) in the last few months, but some in the government have expressed concerns
Read More
Fosun Agrees To Buy Gland Pharma For $1.4 Billion
Hyderabad-based Gland Pharma's founders and US private equity firm KKR, who jointly hold roughly 96 per cent of the drugmaker, will sell almost all of their stake to China's Fosun
Read More
China's Fosun To Sign $1.4 Billion Deal For Gland Pharma Stake
In May, Shanghai Fosun had made a non-binding proposal to buy Gland Pharma, which is backed by KKR & Co
Read More